if you are allergic to ciclosporin or any of the other components of this medication (including those listed in section 6)
with medications that containHypericum perforatum(St. John's Wort).
with medications that contain dabigatrán etexilato (used to prevent blood clots after surgery) or bosentan and aliskirén (used to lower high blood pressure).
If this applies to you, do not take Ciqorin and inform your doctor. If you are unsure, consult your doctor before taking Ciqorin.
Warnings and precautions
Inform your doctor immediately before and during treatment with Ciqorin:
if you experience any signs of infection, such as fever or sore throat. Ciqorin suppresses the immune system and may also affect your body's ability to fight off infections.
if you have liver problems
if you have kidney problems. Your doctor will perform regular blood tests and may change your dose as needed.
if you have high blood pressure. Your doctor will monitor your blood pressure regularly and may administer medication to lower your blood pressure if necessary.
if you have low levels of magnesium in your body. Your doctor may administer magnesium supplements, especially just after your operation if you have undergone a transplant.
if you have high levels of potassium in your blood.
if you suffer from gout.
if you need to receive a vaccine.
If you experience any of the above situations before or during treatment with Ciqorin, inform your doctor immediately.
Sun protection and sunlight
Ciqorin suppresses your immune system. This may increase the risk of developing cancer, mainly of the skin and lymphatic system. Therefore, you should limit your exposure to the sun and UV rays as follows:
Wearing protective clothing.
Applying sunscreen with a high protection factor frequently.
Monitoring during treatment with Ciqorin
Your doctor will monitor:
the levels of ciclosporin in your blood, especially if you have undergone a transplant,
your blood pressure before starting treatment and regularly during treatment,
how your liver and kidneys are functioning,
your lipid levels in blood (fats).
If you have any questions about how Ciqorin works or why you have been prescribed this medication, consult your doctor.
Additionally, if you are taking Ciqorin for a disease other than a transplant(intermediate or posterior uveitis and Behçet's uveitis, atopic dermatitis, severe rheumatoid arthritis, or nephrotic syndrome), do not take Ciqorin:
if you have kidney problems (except for nephrotic syndrome).
if you have an uncontrolled infection.
if you have any type of cancer.
if you have high blood pressure (hypertension) that is not controlled with medication. If your blood pressure is high during treatment and cannot be controlled, your doctor should discontinue treatment with Ciqorin.
If any of these situations apply to you, do not take Ciqorin. If you are unsure, consult your doctor or pharmacist before taking Ciqorin.
If you are being treated for Behçet's uveitis, your doctor will monitor you closely, especially if you experience neurological symptoms (e.g., frequent forgetfulness, changes in personality observed over time, psychiatric or mood disorders, burning sensations in the extremities, decreased sensitivity in the extremities, tingling sensations in the extremities, weakness in the extremities, motor disorders, headaches with or without nausea and vomiting, visual disorders that include limited eye movements).
Your doctor will monitor you closely if you are an elderly person and are being treated for psoriasis or atopic dermatitis. If you have been prescribed Ciqorin to treat your psoriasis or atopic dermatitis, you should not be exposed to UVB or photochemotherapy during treatment.
Children and adolescents
Ciqorin should not be administered to children for indications other than a transplant, except for the treatment of nephrotic syndrome.
Geriatric population (65 years of age and older)
There is limited experience with Ciqorin in elderly patients. Your doctor should monitor how your kidneys are functioning. If you are over 65 years old and have psoriasis or atopic dermatitis, you should only be treated with Ciqorin if your condition is particularly severe.
Taking Ciqorin with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may take any other medication.
Particularly inform your doctor or pharmacist if you are taking any of the following medications before or during treatment with Ciqorin:
Medications that can affect your potassium levels. These include medications that contain potassium, potassium supplements, potassium-sparing diuretics, and some medications that lower your blood pressure.
Metotrexate. It is used to treat tumors, severe psoriasis, and severe rheumatoid arthritis.
Medications that can increase or decrease the levels of ciclosporin (the active ingredient in Ciqorin) in your blood. Your doctor may check the level of ciclosporin in your blood when you start or stop taking other medications.
-Medications that can increase the level of ciclosporin in your blood include:
antibiotics (such as erythromycin or azithromycin), antifungals (voriconazole, itraconazole), medications used for heart disorders or high blood pressure (diltiazem, nicardipine, verapamil, amiodarone), metoclopramide (used to stop vomiting), oral contraceptives, danazol (used to treat menstrual disorders), medications used to treat gout (allopurinol), bile acid and derivatives (used to treat gallstones), protease inhibitors used to treat HIV, imatinib (used to treat leukemia or tumors), colchicine, telaprevir (used to treat hepatitis C), cannabidiol (its use includes, among others, the treatment of epilepsy seizures).
-Medications that can decrease the level of ciclosporin in your blood include:
barbiturates (used to help you sleep), certain anticonvulsant medications (such as carbamazepine or phenytoin), octreotide (used to treat acromegaly or neuroendocrine tumors in the intestine), tuberculosis medications, orlistat (used to help you lose weight), herbal medications that contain St. John's Wort, ticlopidine (used after a stroke), certain medications that lower blood pressure (bosentan), and terbinafine (an antifungal medication, used to treat infections of the toes and fingernails).
Medications that can affect your kidneys. These include:
antibiotics (gentamicin, tobramycin, ciprofloxacin), antifungal medications that contain amphotericin B, medications used to treat urinary tract infections that contain trimethoprim, medications used to treat cancer that contain melphalan, medications used to reduce stomach acid (H2 receptor antagonists), tacrolimus, analgesics (nonsteroidal anti-inflammatory drugs such as diclofenac), bile acid and derivatives (used to reduce fat in the blood).
Nifedipine. It is used to treat high blood pressure and chest pain. You may experience inflamed gums that may grow over your teeth if you take nifedipine during treatment with ciclosporin.
Digoxin (used to treat heart disorders), medications that reduce cholesterol (HMG-CoA reductase inhibitors also called statins), prednisolone, etoposide (used to treat cancer), repaglinide (an oral antidiabetic medication), immunosuppressants (everolimus, sirolimus), ambrisentan, and specific cancer medications called anthracyclines (such as doxorubicin).
If any of these situations apply to you (or you are unsure), inform your doctor or pharmacist before taking Ciqorin.
Hepatitis C
Inform your doctor if you have hepatitis C. Your liver function may change with hepatitis C treatment and may affect the levels of ciclosporin in your blood. Your doctor may need to closely monitor the levels of ciclosporin in your blood and adjust the dose after starting hepatitis C treatment.
Taking Ciqorin with food and drinks
Do not take Ciqorin with grapefruit or grapefruit juice. This may affect the functioning of Ciqorin
Pregnancy and breastfeeding
Consult your doctor or pharmacist before taking this medication. Your doctor will discuss the potential risks of taking Ciqorin during pregnancy.
Inform your doctor if you are pregnant or intend to become pregnant. There is limited experience with Ciqorin in pregnant women. In general, Ciqorin should not be administered during pregnancy. If you need to take this medication, your doctor will discuss the benefits and potential risks of taking it during pregnancy.
Inform your doctor if you are breastfeeding. Breastfeeding is not recommended during treatment with Ciqorin. This is because ciclosporin, the active ingredient, passes into breast milk and may affect your baby.
This medication contains 39.86 mg of alcohol (ethanol) in each capsule. A dose of 500 mg (797.5 mg of ethanol) is equivalent to less than 20 ml of beer or 8 ml of wine.The small amount of alcohol in this medication will have no notable effect.
Ciqorin contains sorbitol
This medication contains 4.92 mg of sorbitol in each capsule.
Ciqorin containshydroxyestearate of macrogolglycerol
It may cause stomach discomfort and diarrhea.
3. How to take Ciqorin
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor again.
Do not take more than the recommended dose.
Your doctor will carefully adjust the dose of this medication to your individual needs. Taking too much of this medication can affect your kidneys. You will have regular blood tests and hospital visits, especially after the transplant. This will allow you to consult with your doctor about your treatment and any problems you may have.
How much Ciqorin should you take
Your doctor will tell you the correct dose of Ciqorin for you. This depends on your body weight and the reason you are taking this medication. Your doctor will also inform you how often you should take your medication.
•In adults:
Organ, bone marrow, and stem cell transplant
The usual total daily dose is between 2 mg and 15 mg per kilogram of body weight. This is divided into two doses.
Higher doses are usually used before and just after your transplant. Lower doses are used once your transplanted organ or bone marrow are stabilized.
Your doctor will adjust the dose to one that is ideal for you. To do this, your doctor may need to do some blood tests.
Endogenous uveitis
The usual total daily dose is between 5 mg and 7 mg per kilogram of body weight. This is divided into two doses.
Nephrotic syndrome
The usual total daily dose for adults is 5 mg per kilogram of body weight. This is divided into two doses. In patients with renal impairment, the first daily dose should not exceed 2.5 mg per kilogram of body weight.
Severe rheumatoid arthritis
The usual total daily dose is between 3 mg and 5 mg per kilogram of body weight. This is divided into two doses.
Psoriasis and atopic dermatitis
The usual total daily dose is between 2.5 mg and 5 mg per kilogram of body weight. This is divided into two doses.
•In children:
Nephrotic syndrome
The usual total daily dose for children is 6 mg per kilogram of body weight. This is divided into two doses. In patients with renal impairment, the first daily dose should not exceed 2.5 mg per kilogram of body weight.
Follow exactly the instructions of your doctor and do not change the dose yourself, even if you feel well.
Conversion of cyclosporin to cyclosporin microemulsion
You may have already been taking another oral cyclosporin. Your doctor may decide to switch you to this medication, Ciqorin.
All these medications contain cyclosporin as the active ingredient.
Ciqorin is a different and improved formulation of cyclosporin. Cyclosporin is better absorbed into the blood with Ciqorin and is less likely to be affected by food intake. This means that the levels of cyclosporin in the blood remain more constant with Ciqorin.
If your doctor switches you from oral cyclosporin to oral cyclosporin microemulsion:
Do not take the previous medication again unless your doctor tells you to.
After the conversion, your doctor will monitor you more closely for a short period of time. This is because of the change in how cyclosporin is absorbed into the blood. Your doctor will ensure that you take the correct dose according to your individual needs.
You may experience some side effects. If this happens, inform your doctor or pharmacist. You may need to reduce your dose. Never reduce your dose yourself, unless your doctor tells you to.
If your doctor switches you from one oral cyclosporin formulation to another
After you switch from one oral cyclosporin formulation to another:
Your doctor will monitor you more closely for a short period of time.
You may experience some side effects. If this happens, inform your doctor or pharmacist. You may need to modify your dose. Never modify your dose yourself, unless your doctor tells you to.
When to take Ciqorin
Take Ciqorin at the same time every day. This is very important if you have had a transplant.
How to take Ciqorin
Your daily dose should always be divided into 2 doses.
Remove the capsules from the blister pack. Swallow the capsules whole with a glass of water.
How long to take Ciqorin
Your doctor will tell you how long you need to take Ciqorin. This depends on whether you are taking it after a transplant or for the treatment of severe skin diseases, rheumatoid arthritis, uveitis, or nephrotic syndrome. In the case of severe skin eruption, treatment usually lasts 8 weeks.
Continue taking Ciqorin for as long as your doctor tells you to.
If you have any doubts about the use of this medication, ask your doctor or pharmacist.
Inform your doctor immediatelyif you notice any of the following serious side effects:
Like other medicines that act on the immune system, ciclosporin can affect your body's ability to fight certain infections and can cause tumors or other malignant diseases, especially of the skin. Signs of infection could be fever or sore throat.
Visual disturbances, lack of coordination, clumsiness, memory loss, difficulty speaking or understanding what others say, and muscle weakness. These could be signs of a brain infection called progressive multifocal leukoencephalopathy.
Brain problems with signs such as seizures, confusion, feeling disoriented, decreased sensitivity, changes in personality, agitation, insomnia, visual disturbances, blindness, coma, paralysis of part or all of the body, torticollis, lack of coordination with or without abnormal speech or eye movement.
Inflammation in the back of the eye that may be associated with blurry vision. It may also affect your vision due to an increase in pressure within the head (benign intracranial hypertension).
Liver damage and alteration with or without yellow discoloration of the eyes or skin, nausea, vision loss, and dark urine.
Kidney problems, which can significantly reduce the amount of urine you produce.
Decrease in the number of red blood cells or platelets. These signs include pale skin, fatigue, shortness of breath, dark urine (sign of red blood cell rupture), unexplained bleeding or bruises, confusion, disorientation, lack of attention, and kidney problems.
Other side effects include:
Very common (may affect more than 1 in 10 people)
Kidney problems.
High blood pressure.
Headache.
Uncontrollable body agitation.
Excessive facial and body hair growth.
Increased blood lipids.
If any of them severely affect you, inform your doctor.
Common (may affect up to 1 in 10 people)
Seizures (convulsions).
Liver problems.
Increased blood sugar.
Fatigue.
Loss of appetite.
Nausea (sensation of dizziness), vomiting, abdominal discomfort, diarrhea.
Excessive hair growth
Acne, hot flashes.
Fever.
Decrease in the number of white blood cells.
Sensation of numbness or tingling.
Muscle pain, muscle spasms.
Stomach ulcer.
Excessive growth of gum tissue that may cover your teeth.
Excess uric acid or potassium in the blood, decrease in blood magnesium levels.
If any of them severely affect you, inform your doctor
Rare (may affect up to 1 in 100 people)
Symptoms of brain alterations including sudden attacks, mental confusion, insomnia, disorientation, visual disturbances, unconsciousness, sensation of weakness in the limbs, movement deterioration.
Skin rash.
Generalized inflammation.
Weight gain.
Decrease in the number of red blood cells and platelets in the blood that may lead to an increased risk of bleeding.
If any of them severely affect you, inform your doctor.
Very rare (may affect up to 1 in 10,000 people)
Inflammation in the back of the eye that may be associated with an increase in pressure within the head and vision deterioration.
If this affects you severely,inform your doctor.
Frequency unknown:Cannot be estimated from available data.
Severe liver problems with and without yellow discoloration of the eyes or skin, nausea (sensation of dizziness), loss of appetite, dark urine, facial, foot, hand, and/or body inflammation.
Bleeding under the skin or purple-colored skin spots, sudden unexplained bleeding.
Migraine or severe headache, often with dizziness or sensation of the same (nausea, vomiting) and light sensitivity.
Pain in legs and feet.
Hearing loss
If any of them severely affect you, inform your doctor.
Other side effects in children and adolescents
No additional side effects are expected in children and adolescents compared to adults.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus.
You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use, https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
5. Preservation of Ciqorin
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and the blister pack after CAD. The expiration date is the last day of the month indicated.
Store below 30°C. Do not freeze. Store in the original packaging to protect it from light and moisture.
Medicines should not be disposed of through drains or in the trash. Dispose of containers and unusedmedications at the SIGREcollection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of containers and unused medications. By doing so, you will help protect the environment.
6. Contents of the packaging and additional information
Composition of Ciqorin
-The active ingredient is cyclosporin
Cada cápsula blanda contiene 25 mg de ciclosporina
-The other components in the capsule content are hydroxyestearate of macrogolglycerol, monolinoleate of glycerol, monoethyl ether of diethyleneglycol, anhydrous ethanol, and D,L-a-tocopherol
-The other components in the capsule coating are gelatin, glycerol, liquid non-crystallized sorbitol (E420), glycine, titanium dioxide (E171), yellow iron oxide (E172), and light liquid paraffin
Appearance of the product and contents of the package
Ciqorin 25 mg soft capsules are soft gelatin capsules of yellow opaque color that contain an oil-like colorless to slightly yellow liquid. Approximate size of 12.2 x 7.6 mm.
The capsules are available in package sizes of 20, 30, 50, 50x1, 60, 90, and 100 in OPA/Alu/PVC-Aluminum blister.
Only some package sizes may be commercially marketed.
Marketing authorization holder and responsible manufacturer
This medicinal product is authorized in the member states of the European Economic Area and in the United Kingdom (Northern Ireland) with the following names:
GermanyCiqorin 25 mg Weichkapseln
SpainCiqorin 25mg soft capsules EFG
ItalyCiqorin
United Kingdom (Northern Ireland) Vanquoral 25 mg Capsules, soft
Last review date of this leaflet: January 2024
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/.
Macrogolglicerol, hidroxiestearato de (108,500 mg mg),
Monooleato de glicerol (80,975 mg mg),
Etanol anhidro (39,875 mg mg),
Solucion de sorbitol 70% (7,42 mg mg),
Glicerol (e 422) (32,47 mg mg)
This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
Talk to a doctor online
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.